Lyn Sittig

About Lyn Sittig

I am a leader with a strong professional focus and background in Governance and Compliance across the healthcare (pharmaceutical and medical device) industry. Proven experience in driving innovation, change and process improvements across various functional areas through collaboration and strong networks. Able to foster cultural change within a matrix environment and achieve organizational goals by removing obstacles, building relationships and collaborating with all levels of the organization, adding value and positively impacting business results. But more than that, I am driven and passionate about doing the right thing: for patients, for the community and for the greater good!My competencies include:• Executive Leadership• Global Governance and standards• Healthcare compliance• Risk management• Divisional PMO Leadership• R&D / New Product Development• Portfolio & Program Management• Strategic Roadmaps & Portfolio Planning• Company-wide Programs and Initiatives• Quality System / Design Controls• Regulatory Body Inspections / Audits• M&A Due Diligence and Integrations• Recall programs• Best practice developer, cultural change agent, cross-functional collaborator, process improvement driver

Experience

1. Worldwide Medical Governance & Compliance Director

   Novartis Oncology

   Oct 2020 — Present · New York, NY, US

   Responsible for driving and implementing an integrated healthcare compliance strategy to ensure adequate oversight and monitoring of scientific engagements (such as advisory boards, preceptorships, investigator meetings, congresses, scientific standalone, etc.). Responsible for strategic development, management & provision of governance for these engagements. Drive collaboration and partnership across functions and divisions to further drive governance alignment holistically.Rotational medical review member of events (ad boards, preceptorships, investigator meetings, symposia) and external funding requests (grants & sponsorships) review boards.Contributing member of the Hematology and Solid Tumor Franchise leadership teams. Envisioned and led the revamp of the governance framework for the enterprise HCP engagement process which will lead to improved oversight of risks and opportunities enabling stronger, strategic decision making and co-creation of the future state across global, region and countries.Advanced initiative to integrate gender diversity and equity in external engagements.Contributed to the delivery of a new principles-based content approval standard aiming to result in duplicate approvals and streamlined process.Advanced pilot program for medical review of promotional material leveraging agency support and development of modular content.

Education

• George Mason University

  Bachelors, Anthropology

• Ramapo College of New Jersey

  Master of Business Administration (MBA)

  2016 — 2018

• The George Washington University

  MSc, Project Management

  2004 — 2007

Skills

• Project Management
• Cross-Functional Team Leadership
• Program Management
• Management
• Fda
• Medical Devices
• Quality System
• Product Development
• Design Control
• Leadership
• Product Launch
• Acquisition Integration
• Certified Project Manager
• R&D
• Gmp
• Process Improvement
• Strategy
• Product Management
• Iso 13485
• Quality Assurance
• Pmp
• Vendor Management
• Pmo
• Project Portfolio Management
• Strategic Planning
• Team Leadership
• Strategic Roadmaps
• Resource Management
• Agile Project Management
• Orthopedics
• Business Development
• U.s. Food and Drug Administration (Fda)
• Business Process Improvement
• Research and Development (R&D)
• Executive Level Interaction
• Executive-Level Communication
• Team Management
• Business Strategy
• Managerial Finance
• Enterprise Project Management (Epm)